Incidence and serotype distribution of invasive group B streptococcal disease in young infants: A multi-country observational study

BMC Pediatrics

Volumn 15, Issue 1, 2015, Pages

  Rivera, Luis ^a   Sáez Llorens, Xavier ^b   Feris Iglesias, Jesus ^c   Ip, Margaret ^d   Saha, Samir ^e   Adrian, Peter V ^f   Madhi, Shabir A ^f,g   Boudville, Irving C ^h   Cunnington, Marianne C ⁱ   Casellas, Javier M ^h   Slobod, Karen S ^h  

^a Perinatology   (Dominican Republic)

^b UNIVERSIDAD DE PANAMÁ   (Panama)

^c School of Medicine   (Dominican Republic)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e DHAKA SHISHU HOSPITAL   (Bangladesh)

^f UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^g NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^h Novartis Vaccines and Diagnostics Inc   (United States)

ⁱ Global Development   (United Kingdom)

Author keywords

Asia; Group B streptococcal disease; Incidence; Latin America; Serotype distribution

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASIA; BACTERIUM CULTURE; BACTERIUM ISOLATE; BANGLADESH; BIRTH WEIGHT; BLACK PERSON; CASE FATALITY RATE; CAUCASIAN; CHILD; CHINESE; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DOMINICAN REPUBLIC; FEMALE; GESTATIONAL AGE; GROUP B STREPTOCOCCAL INFECTION; HISPANIC; HONG KONG; HUMAN; INCIDENCE; INFANT; LIMIT OF DETECTION; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MULTICENTER STUDY; OBSERVATIONAL STUDY; PANAMA; SEROTYPE; SOUTH AND CENTRAL AMERICA; STREPTOCOCCUS AGALACTIAE; TERTIARY CARE CENTER; CLASSIFICATION; CLINICAL TRIAL; GENETICS; MICROBIOLOGY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; RISK FACTOR; STREPTOCOCCAL INFECTIONS; TRANSMISSION; VERTICAL TRANSMISSION;

ANTIBIOTIC PROPHYLAXIS; BANGLADESH; DOMINICAN REPUBLIC; FEMALE; HONG KONG; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PANAMA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; SEROGROUP; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 84942673528     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/s12887-015-0460-2     Document Type: Article

References (29)

1. Heath PT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL, Tighe H, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet. 2004;363:292-4.
2. Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet. 2012;379:547-56.
3. Dagnew AF, Cunnington MC, Dube Q, Edwards MS, French N, Heyderman RS, et al. Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis. 2012;55:91-102.
4. Stoll BJ, Schuchat A. Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J. 1998;17:499-503.
5. Schrag SJ, Zywicki S, Farley M, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. New Engl J Med. 2000;342:15-20.
6. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med. 2002;347:233-9.
7. Stoll BJ, Hansen NI, Sánchez PJ, Faix RG, Poindexter BB, Van Meurs KP, et al. Early onset neonatal sepsis: the burden of Group B streptococcal and E. coli disease continues. Pediatrics. 2011;127:817-26.
8. Schrag SJ, Group B. Streptococcal vaccine for resource-poor countries. Lancet. 2011;378:11-2.
9. Healy CM. Vaccines in pregnant women and research initiatives. Clin Obstet Gynecol. 2012;55:474-86.
10. Darmstadt GL, Saha SK, Choi Y, El Arifeen S, Ahmed NU, Bari S, et al. Bangladesh Projahnmo-2 (Mirzapur) Study Group. Population-based incidence and etiology of community-acquired neonatal bacteremia in Mirzapur, Bangladesh: an observational study. J Infect Dis. 2009;200:906-15.
11. Afshar B, Broughton K, Creti R, Decheva A, Hufnagel M, Kriz P, et al. Members of the DEVANI Study Group, Efstratiou A. International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (Group B streptococci). JClin Microbiol. 2011;49:1475-82.
12. Fleiss JL. Statistical methods for rates and proportions. New York: John Riley; 1981 p. 14-5.
13. Madhi SA, Radebe K, Crewe-Brown H, Frasch CE, Arakere G, Mokhachane M, et al. High burden of invasive Streptococcus agalactiae disease in South African infants. Ann Trop Paediatr. 2003;23:15-23.
14. Cutland CL, Madhi SA, Zell ER, Kuwanda L, Laque M, Groome M, et al. Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet. 2009;374:1909-16.
15. Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1-36.
16. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ. 1992;41:25-32.
17. Fernandez J, Sanchez J, Feris JM, Gómez E, Serulle Y, Demorizi J, et al. Prevalencia de estreptococo grupo B (EGB) en embarazadas dominicanas. Rev Panam Infectol. 2006;8:26-32.
18. Chan GJ, Modak JK, Mahmud AA, Baqui AH, Black RE, Saha SK. Maternal and neonatal colonization in Bangladesh: prevalence, etiologies and risk factors. J Perinatol. 2013;33:971-6.
19. Tsui MH, Ip M, Ng PC, Sahota DS, Leung TN, Lau TK. Change in prevalence of Group B Streptococcus maternal colonization in Hong Kong. Hong Kong Med J. 2009;15:414-9.
20. Anon. Disparities in universal prenatal screening for group B streptococcus-North Carolina, 2002-2003. Morb Mortal Wkly Rep. 2005;54:700-3.
21. Anon. Trends in perinatal group B streptococcal disease-United States, 2000-2006. Morb Mortal Wkly Rep. 2009;58:109-12.
22. Regan JA, Klebanoff MA, Nugent RP. The epidemiology of group B streptococcal colonization in pregnancy. Obstet Gynecol. 1991;77:604-10.
23. Weston EJ, Pondo T, Lewis MM, Martell-Cleary P, Morin C, Jewell B, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011;30:937-41.
24. Zhaidi AKM, Thaver D, Asad S, Khan TA. Pathogens associated with sepsis in newborns and young infants in developing countries. Pediatr Infect Dis J. 2009;28:S10-8.
25. Weinstein MP. Blood culture contamination: persisting problems and partial progress. J Clin Microbiol. 2003;41:2275-8.
26. Lakshmi V. Culture of body fluids using the bact/alert system. Indian J Med Microbiol. 2001;19:44-50.
27. Choudhury N, Moran AC, Alam MA, Ahsan KZ, Rashid SF, Streatfield PK. Beliefs and practices during pregnancy and childbirth in urban slums of Dhaka, Bangladesh. BMC Public Health. 2012;12:791.
28. Jones N, Bohnsack JF, Takahashi S, Oliver KA, Chan MS, Kunst F, et al. Multilocus sequence typing system for group B streptococcus. J Clin Microbiol. 2003;41:e2530-6.
29. Luan SL, Granlund M, Sellin M, Lagergard T, Spratt BG, Norgren M. Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J Clin Microbiol. 2005;43:e3727-33.